188.50
+0.12
+(0.06%)
At close: March 3 at 5:35:51 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 26 | 25 | 34 | 33 |
Avg. Estimate | 3.02B | 3.79B | 14.47B | 15.5B |
Low Estimate | 3B | 3.71B | 14.25B | 15B |
High Estimate | 3.05B | 3.91B | 14.8B | 16.11B |
Year Ago Sales | 2.89B | 3.56B | 13.69B | 14.47B |
Sales Growth (year/est) | 4.50% | 6.63% | 5.71% | 7.12% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
E3X1.DE | -- | -- | -- | -- |
S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
Maintains | Citigroup: Neutral to Neutral | 2/11/2025 |
Maintains | Susquehanna: Neutral to Neutral | 2/10/2025 |
Maintains | BMO Capital: Market Perform to Market Perform | 2/10/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 2/7/2025 |
Reiterates | Cantor Fitzgerald: Neutral to Neutral | 2/7/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 2/7/2025 |